Springer Nature OAopen access
Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension Study
Medicine & Public Health, Internal Medicine, Neurology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 180567
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.